Opportunity Information: Apply for RFA NS 14 011
Apply for RFA NS 14 011
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NINDS Exploratory Grant Program in Parkinsons Disease Research (P20)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders.
- This funding opportunity was created on May 30, 2014 and posted on May 30, 2014.
- Applicants must submit their applications by Sep 29, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: Private institutions of higher education For profit organizations other than small businesses Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments Public housing authorities/Indian housing authorities Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) State governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public and State controlled institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NINDS Exploratory Grant Program in Parkinsons Disease Research (P20) is a National Institutes of Health funding opportunity designed to help research groups form or strengthen multidisciplinary collaborations focused on Parkinsons disease (PD). PD is described in the announcement as a chronic, progressive movement disorder affecting at least half a million people in the United States, with a major ripple effect on caregivers and families. Because PD most commonly begins in a persons sixties, and because the U.S. population is aging, the overall burden of PD is expected to rise. Despite meaningful scientific progress, the FOA emphasizes that the underlying causes and full biological complexity of PD are still not completely understood, and current therapies mainly treat symptoms rather than slowing or stopping disease progression. Against that backdrop, the program is built around the idea that complex PD problems are often better tackled by teams that combine expertise across disciplines, but that building those teams, aligning strategy, and generating the early data needed to justify larger center-level work takes time and dedicated support.
This FOA (Funding Opportunity Announcement) solicits P20 exploratory grant applications that focus on planning and initiating synergistic research activities that can move PD research and treatment forward. The emphasis is on creating and formalizing collaborative structures, establishing shared approaches, and generating the foundation of research discovery needed to address new or emerging questions in PD. A key feature of the program is that it is meant to be a stepping stone: successful P20 projects are expected to position applicants for a later, more comprehensive application to the NINDS Morris K. Udall Center of Excellence program (P50), which supports larger collaborative, multidisciplinary PD research centers. In other words, the P20 is intended to help groups get organized and productive enough to compete for a full center award, rather than to serve as long-term support for already mature programs.
The announcement also makes clear what the program is not trying to do. It is intended to foster innovative collaborations and support new projects, not to fund the continuation of projects that are already underway. That focus signals that reviewers will likely be looking for proposals where the P20 funding fills a real gap: enabling a new partnership, launching coordinated pilot efforts, building shared resources or workflows, and collecting preliminary evidence that the team can work together effectively on a defined PD challenge.
Administratively, this is a discretionary grant opportunity (not a formula or entitlement program) in the health funding activity category, under CFDA 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders). The FOA number is RFA-NS-14-011, and it was posted May 30, 2014, with an application due date of September 29, 2014, and an archive date of October 30, 2014. The estimated total funding available was $1,000,000, with an award ceiling of $250,000, and there is no cost sharing or matching requirement indicated.
Eligibility is broad and includes many types of U.S.-based organizations, such as public and state controlled institutions of higher education, private institutions of higher education, nonprofits (including 501(c)(3) and non-501(c)(3) entities), state, county, city or township governments, special district governments, independent school districts, public housing authorities/Indian housing authorities, small businesses, and for-profit organizations other than small businesses. The announcement also explicitly includes eligibility for several institution types such as HBCUs, Hispanic-serving institutions, tribal colleges and universities, Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions, as well as faith-based or community-based organizations and eligible federal agencies. At the same time, it specifies that non-U.S. (foreign) organizations and foreign institutions are not eligible to apply, and that non-U.S. components of U.S. organizations are not eligible to apply. However, foreign components as defined in the NIH Grants Policy Statement are allowed, which typically means certain internationally based elements may be included when justified, even though the applicant organization itself must be eligible and primarily U.S.-based.
Overall, the opportunity is best understood as seed funding for building a coordinated, team-based PD research effort with a clear trajectory: use the P20 period to organize the collaboration, define and test a shared strategy, generate early results, and become competitive for a subsequent Udall Center (P50) application that can sustain a larger, longer-term multidisciplinary program aimed at advancing understanding and treatment of Parkinsons disease.
FAQs: NINDS Exploratory Grant Program in Parkinsons Disease Research (P20)
What is the NINDS Exploratory Grant Program in Parkinsons Disease Research (P20)?
It is an NIH/NINDS funding opportunity that supports planning and initiation of multidisciplinary, team-based Parkinsons disease (PD) research activities. The program is designed to help research groups form or strengthen collaborations, establish shared approaches, and generate early foundations for future, larger center-level work.
What problem is this program trying to address?
The announcement frames PD as a chronic, progressive movement disorder affecting at least half a million people in the United States, with major impacts on caregivers and families. It notes that the U.S. population is aging, PD commonly begins in a persons sixties, and overall burden is expected to increase. Despite progress, the FOA emphasizes that the underlying causes and full biological complexity of PD are not fully understood and current therapies largely treat symptoms rather than slowing or stopping progression.
What is the main purpose of the P20 awards in this FOA?
The purpose is to support exploratory, synergistic activities that move PD research and treatment forward by building and formalizing collaborative structures, aligning strategies across disciplines, establishing shared approaches, and producing early research discovery foundations.
Is this opportunity intended to be a stepping stone to a larger program?
Yes. The FOA describes the P20 as a stepping stone intended to position successful teams for a later, more comprehensive application to the NINDS Morris K. Udall Center of Excellence program (P50), which supports larger multidisciplinary PD research centers.
Is the P20 meant to provide long-term support for established, mature PD centers?
No. The FOA emphasizes that the P20 is intended to help groups get organized and productive enough to compete for a full center award, rather than serve as long-term support for already mature programs.
What kinds of activities or outcomes does the FOA emphasize for P20 projects?
The FOA emphasizes planning and initiating synergistic research activities, formalizing collaboration, establishing shared methods or workflows, building coordinated approaches, and generating early data or evidence that helps justify later center-level work.
Does the FOA support the continuation of projects that are already underway?
The announcement states the program is intended to foster innovative collaborations and support new projects, not to fund continuation of projects that are already underway.
What would reviewers likely look for based on the description provided?
Based on the FOA description, reviewers would likely look for proposals where P20 funds clearly fill a gap by enabling a new partnership, launching coordinated pilot efforts, building shared resources or workflows, and producing preliminary evidence that the team can work together effectively on a defined PD challenge.
What disease area must the proposed work focus on?
The FOA is specifically focused on Parkinsons disease research, including efforts aimed at advancing understanding and treatment of PD.
What is the FOA number for this opportunity?
The FOA number is RFA-NS-14-011.
Who is the sponsoring agency?
The opportunity is offered through the National Institutes of Health (NIH), specifically the National Institute of Neurological Disorders and Stroke (NINDS).
What is the CFDA number and program category listed?
The CFDA is 93.853, listed as Extramural Research Programs in the Neurosciences and Neurological Disorders, under the health funding activity category.
What type of grant is this (formula/entitlement vs. discretionary)?
The announcement describes it as a discretionary grant opportunity, not a formula or entitlement program.
How much total funding was estimated to be available under this FOA?
The estimated total funding available was $1,000,000.
What is the award ceiling for individual awards under this FOA?
The award ceiling listed in the provided description is $250,000.
Is cost sharing or matching required?
No cost sharing or matching requirement is indicated in the information provided.
When was the FOA posted and what were the key dates?
The FOA was posted May 30, 2014. The application due date was September 29, 2014, and the archive date was October 30, 2014.
What kinds of organizations are eligible to apply?
Eligibility is broad for U.S.-based organizations and includes public and state controlled institutions of higher education, private institutions of higher education, nonprofits (including 501(c)(3) and non-501(c)(3) entities), and many government entities (state, county, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities). It also includes small businesses and for-profit organizations other than small businesses.
Are minority-serving institutions specifically included?
Yes. The announcement explicitly includes institution types such as HBCUs, Hispanic-serving institutions, tribal colleges and universities, Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions.
Are faith-based or community-based organizations eligible?
Yes. The announcement explicitly includes faith-based or community-based organizations among eligible applicants.
Are federal agencies eligible to apply?
The announcement indicates eligible federal agencies are included among eligible applicants.
Are foreign (non-U.S.) organizations eligible to apply?
No. The FOA specifies that non-U.S. (foreign) organizations and foreign institutions are not eligible to apply.
Can a U.S. organization apply if it has non-U.S. components?
The FOA specifies that non-U.S. components of U.S. organizations are not eligible to apply. However, it also states that foreign components (as defined in the NIH Grants Policy Statement) are allowed, meaning certain internationally based elements may be included when justified, even though the applicant organization must be eligible and primarily U.S.-based.
What is the overall trajectory the FOA is trying to create for applicants?
The FOA presents the P20 as seed funding to organize a coordinated, team-based PD research effort, define and test a shared strategy, generate early results, and become competitive for a subsequent NINDS Morris K. Udall Center of Excellence (P50) application.
Browse more opportunities from the same category: Health
Next opportunity: DoD Prostate Cancer Collaborative Undergraduate Historically Black Colleges and Universities Student Summer Training Program Award
Previous opportunity: Juvenile Justice and Pre Trial Detention in Guatemala, El Salvador, and Panama
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA NS 14 011
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA NS 14 011) also looked into and applied for these:
| Funding Opportunity |
|---|
| Addiction Technology Transfer Center Center of Excellence on Behavioral Health for Racial/Ethnic Minority Young Men Who Have Sex with Men (YMSM) and Lesbian, Gay, Bi sexual, Transgender Populations (LGBT) (Short Title ATTC CoE) Apply for TI 14 014 Funding Number: TI 14 014 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $676,875 |
| Development of Sample Sparing Assays for Monitoring Immune Responses (U24) Apply for RFA AI 14 027 Funding Number: RFA AI 14 027 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Programs to Reduce Obesity in High Obesity Areas Apply for CDC RFA DP14 1416 Funding Number: CDC RFA DP14 1416 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,600,000 |
| Translational Programs in Lung Diseases (P01) Apply for PAR 14 245 Funding Number: PAR 14 245 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| Increasing IIS Sentinel Site Capacity for Enhanced Program Support Apply for CDC RFA IP14 1407 Funding Number: CDC RFA IP14 1407 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (IPCP MBP) (U19) Apply for RFA AI 14 025 Funding Number: RFA AI 14 025 Agency: National Institutes of Health Category: Health Funding Amount: $2,600,000 |
| Public Health Systems Capacity Building in India Apply for CDC RFA GH14 1416 Funding Number: CDC RFA GH14 1416 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $750,000 |
| NIOSH Support for Conferences and Scientific Meetings (U13) Apply for PAR 14 229 Funding Number: PAR 14 229 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $30,000 |
| Family Planning, Maternal, Newborn and Child Health (FP/MNCH) Interventions Apply for RFA 306 14 000006 Funding Number: RFA 306 14 000006 Agency: Afghanistan USAID Kabul Category: Health Funding Amount: $60,000,000 |
| Clinical Trial on the Effects of Interventions Aiming to Reduce Chronic Inflammation in Older Adults Pilot Phase (U01) Apply for RFA AG 15 006 Funding Number: RFA AG 15 006 Agency: National Institutes of Health Category: Health Funding Amount: $1,857,000 |
| Lab to Marketplace Tools for Brain and Behavioral Research (R43/R44) Apply for PA 14 250 Funding Number: PA 14 250 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| State Systems Development Initiative Grant Program Apply for HRSA 15 002 Funding Number: HRSA 15 002 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| RWANDA HEALTH SYSTEMS STRENGTHENING (RHSS) ACTIVITY Apply for RFA69614000001 Funding Number: RFA69614000001 Agency: Rwanda USAID Kigali Category: Health Funding Amount: $24,900,000 |
| Statewide Peer Network Development Program for Recovery and Resiliency Grants (Short Title Statewide Peer Networks for R Apply for SM 14 023 Funding Number: SM 14 023 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $100,000 |
| Limited Competition Large Scale Collaborative Project Award Renewals (U54) Apply for RFA GM 15 003 Funding Number: RFA GM 15 003 Agency: National Institutes of Health Category: Health Funding Amount: $5,000,000 |
| Developing and Improving Institutional Animal Resources (G20) Apply for PAR 14 251 Funding Number: PAR 14 251 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Specialized Alcohol Research Centers (P50) Apply for RFA AA 15 001 Funding Number: RFA AA 15 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,800,000 |
| Comprehensive Alcohol Research Centers (P60) Apply for RFA AA 15 002 Funding Number: RFA AA 15 002 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44) Apply for PAR 14 252 Funding Number: PAR 14 252 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention Infrastructure Resource Access (X01) Apply for PAR 14 253 Funding Number: PAR 14 253 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 14 011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
